论文部分内容阅读
1前言作为生物科研中发展最迅速、投资最大的领域,生物制药已经越来越受到学术界的关注。大量研究表明,生物制药SCM运营模式的改善能够大大降低生物科研的投入成本。当今国际生物制药的运作环境比较分散且复杂,这会严重影响生物制药业的运营效率,也使得生物制药SCM体系的构建显得尤为重要与紧迫。我国对生物制药供应链的研究仍处于起步阶段,还没有开展系统的研究。而西方发达国家对于生物制药供应链的研究主要集中于该供应链的改进能够在多大程度上降低该领域的
1 Introduction As the fastest-growing and most-invested area in biological research, biopharmaceuticals have drawn increasing attention from academia. Numerous studies show that the improvement of the operating mode of biopharmaceutical SCM can greatly reduce the cost of biotechnology research. The current international biopharmaceutical operation environment is relatively fragmented and complex, which will seriously affect the operational efficiency of the biopharmaceutical industry, but also makes the construction of biopharmaceutical SCM system is particularly important and urgent. China’s research on biopharmaceutical supply chain is still in its infancy, and no systematic research has been carried out yet. However, the western developed countries’ research on biopharmaceutical supply chain mainly focuses on the extent to which the improvement of the supply chain can reduce the